Nektar Therapeutics (NKTR) Earnings Date & Reports

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NKTR is expected to report earnings to fall 648.67% to -16 cents per share on May 08

Nektar Therapeutics NKTR Stock Earnings Reports

Q1'25

Est.

$-0.16

Q4'24

Beat

by $0.19

Q3'24

Beat

by $0.02

Q2'24

Missed

by $0.06

Q1'24

Missed

by $0.04

The last earnings report on March 12 showed earnings per share of 2 cents, beating the estimate of -15 cents. With 249.14K shares outstanding, the current market capitalization sits at 123.57M.

View a ticker or compare two or three

Compare

NKTR